DEFA14A: CalciMedica, Inc. to Hold Annual Meeting on August 27, 2024; Proposes Director Elections, Auditor Ratification, and Equity Incentive Plan Amendment

CalciMedica, Inc. will hold its annual meeting on August 27, 2024, to vote on the election of directors, ratification of auditors, and an amendment to the equity incentive plan.

Summary

• CalciMedica, Inc. is holding its annual meeting of stockholders on August 27, 2024.
• Stockholders of record as of June 28, 2024, are eligible to vote.
• The meeting will be held live via the Internet.
• The proposals include electing two Class I directors (Eric Bjerkholt and Fred Middleton) for a three-year term until the 2027 annual meeting.
• Stockholders will vote to ratify the appointment of Moss Adams LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• An amendment to the CalciMedica, Inc. 2023 Equity Incentive Plan will be voted on, which includes increasing the number of shares authorized for issuance by 1,500,000 shares.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating routine corporate governance activities. The sentiment is neutral to slightly positive due to the company engaging with shareholders.

Positives

• The proposal to amend the 2023 Equity Incentive Plan could help attract and retain talent by offering more equity-based compensation.

Future Outlook

The document outlines the proposals to be voted on at the annual meeting, which will influence the company's governance and compensation structure.

Industry Context

Proxy statements and annual meetings are standard practice for publicly traded companies, ensuring shareholder participation in key decisions.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• Employees may be affected by the changes to the equity incentive plan.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold its annual meeting on August 27, 2024, and announce the results of the votes.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, CalciMedica, Directors, Auditor, Equity Incentive Plan